Health professionals: Applying for access to the CGM Initiative through the NDSS
To access CGM and Flash GM products through the CGM Initiative as part of the NDSS, the person will need to be assessed by an authorised health professional to determine whether they meet specific eligibility criteria and decide which is the most suitable product for them to use as part of their diabetes management. Not all products are suitable for everyone.
You can access details and information, relevant to the eligible groups, including eligibility criteria, directly from these links:
- Children and young people aged under 21 years with type 1 diabetes
- Children and young people under 21 years with conditions very similar to type 1 diabetes who require insulin
- People with type 1 diabetes aged 21 years or older who have valid concessional status
- Women with type 1 diabetes who are actively planning pregnancy, pregnant, or immediately post-pregnancy
Submitting a standard application
To submit an application, a completed Continuous and Flash Glucose Monitoring Access form prepared and certified by an authorised health professional, should be:
- emailed to the NDSS at email@example.com (preferred option), or
- posted to GPO Box 9824 in your capital city, or
- faxed to 1300 536 953.
Frequently asked questions
This resource was developed for health professionals to provide general information on accessing CGM products through the NDSS, how you can help people applying for access, details about eligibility criteria and how to complete Continuous and Flash Glucose Monitoring Access forms.
Continuous glucose monitoring booklet
This booklet aims to provide information for health professionals about fully subsidised continuous glucose monitoring devices.
- Continuous glucose monitoring booklet: information for health professionals
Indications for use
The CGM and Flash GM device summary and compatibility chart contains information about CGM and Flash GM devices fully subsidised through the CGM Initiative as part of the NDSS, their compatibility with insulin pumps and smartphone and smart devices, and links to guidelines about appropriate use, including manufacturers documentation.
The Therapeutic Goods Administration approves CGM and Flash GM devices that can be lawfully supplied in Australia and these are listed in the Australian Register of Therapeutic Goods (ARTG).
By certifying Continuous and Flash Glucose Monitoring Access forms for a person, you are confirming that you are aware that not all CGM and Flash GM products are indicated for use in all conditions or all age groups, and that you have considered available advice about the selected device. This includes advice on the relevant ARTG listing about appropriate use for specific conditions.
The CGM and Flash GM device summary and compatibility chart contains links to the ARTG listings.
Submitting an extended access application
Sometimes pregnancy planning may need to continue after the initial 12 months. Applications for extensions require documented evidence of need from both a diabetes and a pregnancy health professional. This documentation should confirm ongoing active pregnancy planning.
Applications for an extension of access to CGM and Flash GM products for a further six-month period, are considered on a case-by-case basis. At the end of this six-month period, one further six-month extension may be granted subject to the same documentation being provided.
Find out more about: